CLINICAL RESEARCH: CARDIAC EFFECTS OF SLEEP APNEA
High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy
Mackram F. Eleid, MD*,
Tomas Konecny, MD ,
Marek Orban, MD ,
Partho P. Sengupta, MD, DM*,
Virend K. Somers, MD, PhD ,
James M. Parish, MD*,
Farouk Mookadam, MBBS*,
Peter A. Brady, MD ,
Barbara L. Sullivan, NP*,
Bijoy K. Khandheria, MD*,
Steve R. Ommen, MD and
A. Jamil Tajik, MD*,*
* Divisions of Cardiovascular and Pulmonary Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Scottsdale, Arizona
Divisions of Cardiovascular and Pulmonary Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
Manuscript received March 19, 2009;
revised manuscript received July 20, 2009,
accepted July 30, 2009.
* Reprint requests and correspondence: Dr. A. Jamil Tajik, Cardiovascular Diseases, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, Arizona 85259 (Email: jtajik{at}mayo.edu).
Objectives: We sought to determine the prevalence of nocturnal oxygen desaturation and obstructive sleep apnea (OSA) in a population of patients with hypertrophic cardiomyopathy (HCM).
Background: The coexistence of sleep apnea and HCM, 2 common cardiovascular conditions, has been largely unrecognized in the treatment of patients with HCM. The nocturnal hypoxia-induced hyperadrenergic state in OSA is expected to worsen hemodynamics and outcomes in HCM.
Methods: One hundred subjects with HCM between June 1, 2006, and July 14, 2008, were screened with nocturnal oximetry. Clinical variables were collected for statistical analysis. Oximetry was classified abnormal (suspicion of sleep-disordered breathing) in the presence of repetitive desaturation ( 5 events/h) followed by a rapid return to baseline oxygen saturation (SaO2) level with a decrease of 4% and threshold of 90%.
Results: Seventy-one (71%) patients with HCM had abnormal nocturnal oximetry (71 ± 9%, 95% confidence interval: 62% to 80%). Subjects with abnormal oximetry were older (age 59.5 ± 15.3 years) and more were hypertensive (n = 39 [55%]) than those with normal oximetry (age 45.8 ± 18.5 years, n = 9 [31%], p < 0.001, p = 0.03). Patients with HCM were more symptomatic in the presence of abnormal oximetry (New York Heart Association functional class II to III) (62% vs. 83%, p = 0.023). HCM patients had a higher prevalence of abnormal nocturnal oximetry (n = 71, 71%) compared with a control group of similar age and sex distribution (n = 49, 49%) (p = 0.001).
Conclusions: Abnormal nocturnal oximetry is common in patients with HCM, suggesting that OSA is prevalent. OSA may impact hemodynamics and symptoms in HCM. Further studies are needed to determine the long-term benefit of OSA treatment on hemodynamics and disease progression in HCM.
Key Words: hypertrophic apnea oximetry obstructive
|
Abbreviations and Acronyms
| | BMI = body mass index | | CPAP = continuous positive airway pressure | | HCM = hypertrophic cardiomyopathy | | LV = left ventricle/ventricular | | NYHA = New York Heart Association | | OSA = obstructive sleep apnea | | SaO2
= oxygen saturation |
|
Related Articles
-
Obstructive Sleep Apnea: A Respiratory Syndrome With Protean Cardiovascular Manifestations
- Ian Wilcox and Christopher Semsarian
J. Am. Coll. Cardiol. 2009 54: 1810-1812.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A40.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. P. Pedrosa, L. F. Drager, P. R. Genta, A. C. S. Amaro, M. O. Antunes, A. Y. Matsumoto, E. Arteaga, C. Mady, and G. Lorenzi-Filho
Obstructive Sleep Apnea Is Common and Independently Associated With Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
Chest,
May 1, 2010;
137(5):
1078 - 1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Wilcox and C. Semsarian
Obstructive Sleep Apnea: A Respiratory Syndrome With Protean Cardiovascular Manifestations
J. Am. Coll. Cardiol.,
November 3, 2009;
54(19):
1810 - 1812.
[Full Text]
[PDF]
|
 |
|
|